tiprankstipranks
Analyst Profile
Followed by 18 other investors
.
Drew Jones

Drew Jones

Stephens
Wall Street Analyst
Ranked #776 out of 8,045 Analysts on TipRanks (#1,259 out of 21,519 overall experts)

Success Rate

63%
43 out of 68 Profitable Transactions

Average Return

19.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Drew Jones's ratings since 2011 and opened each position for the duration of 1 Year:
63.24% of your transactions would have been profitable with an average return of 19.4%

Stock Rating Distribution

111Ratings
61.26% Buy
38.74% Hold
0.00% Sell
Distribution of Drew Jones's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Pacific Biosciences
(PACB)
Rating Type:Buy
Dates:May 04, 2018 - Apr 02, 2019
Gain:215.80%
The most profitable rating made by Drew Jones

Drew Jones's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Accuray
May 06, 2011
Buy
Reiterated
0%
-11.40%
1
Cerus
Feb 05, 2016
Buy
Reiterated
$9.00
(75.44% Upside)
0%
-23.00%
1
Veracyte
Jun 13, 2016
Buy
Reiterated
$14.00
(-45.84% Downside)
100%
+33.15%
2
Trinity Biotech
Oct 05, 2016
Hold
Downgraded
0%
-39.80%
2
ABAX
Abaxis Inc
Jan 26, 2018
Hold
Reiterated
0.00%
2
Exact Sciences
Aug 27, 2018
Hold
Reiterated
$75.00
(69.53% Upside)
0%
-27.60%
12
Neogen
Oct 03, 2018
Hold
Reiterated
$75.00
(236.62% Upside)
100%
+33.30%
7
West Pharmaceutical Services
Oct 26, 2018
Hold
Reiterated
$100.00
(-70.66% Downside)
0.00%
5
Repligen
Nov 02, 2018
Buy
Reiterated
$65.00
(-74.58% Downside)
100%
+27.54%
5
Catalent
Nov 06, 2018
Hold
Reiterated
$41.00
(-63.01% Downside)
100%
+32.30%
7
List of latest recommendations made by Drew Jones. Click to expand and see Drew Jones's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More